Mycobacterium Simiae Infection in a Person With Cystic Fibrosis
Open Access
- 20 October 2020
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 12 (10)
Abstract
Although non-tuberculous mycobacteria can be found in the airways of people with cystic fibrosis (pwCF), their role as pathogens may be uncertain, and treatment is problematic. We report the first case of Mycobacterium simiae (M. simiae), often associated with asymptomatic disease or colonisation, which caused pulmonary infection requiring treatment in a pwCF. This report shows that M. simiae, rare in pwCF in the United Kingdom, can cause significant illness and highlights the diagnostic difficulty in individuals with positive smear mycobacteria that can be mistaken initially for pulmonary tuberculosis (TB).Keywords
This publication has 9 references indexed in Scilit:
- Mycobacterium simiae: Harmless colonizer or deadly pathogen?PLOS Pathogens, 2020
- Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 PatientsAntimicrobial Agents and Chemotherapy, 2018
- Travelling abroad with cystic fibrosis: Assessment of risks and healthcare requirementsRespiratory Medicine, 2017
- Infection in cystic fibrosis: impact of the environment and climateExpert Review of Respiratory Medicine, 2016
- Mental health in cystic fibrosis: turning the tideThorax, 2015
- US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosisThorax, 2015
- The water environment as a source of potentially pathogenic mycobacteriaJournal of Water and Health, 2013
- Fatal disseminated Mycobacterium simiae infection in a non-HIV patientInternational Journal of Infectious Diseases, 2009
- Clinical relevance ofMycobacterium simiaein pulmonary samplesEuropean Respiratory Journal, 2007